Thomas Gad, CHIEF BUSINESS OFFICER at Y-mAbs Therapeutics, Inc. (YMAB), sold 21,620 shares at $5.23 ($113K) on 2025-03-07, disclosed to the SEC on 2025-03-11.
Open-market sale of $113k YMAB by CHIEF BUSINESS OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.23 | 10,810 | $57K | 50.0% |
| 2 | $5.23 | 10,810 | $57K | 50.0% |
| Total | $5.23 avg | 21,620 | $113K | 100% |
| Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |
| YMAB | SELL | 2023-12-15 | $1.0M | — | Filing → |